Precision Medicine
Singapore Targets Widespread Implementation of Precision Medicine, Launches Phase II of its 10-Year Plan
2021-04-10
How Can Organoid and Mouse Models Boost Oncology Preclinical Trials? – Highlights from the Crown Biosciences Symposium
2021-03-10Partner
Taiwan Kicks off 2020 Healthcare Expo, Targeting Strategies to Boost Digital Transformation in Biopharma Industry
2020-12-03
Advance Precision Medicine by Applying Circulating Tumor Cells for Anti-Cancer Drug Screen
2020-10-20Partner
2019 CSCO China, with highlights on proteomics-driven precision medicine, oncology treatment and quality control, and breakthroughs in drug developments
2019-11-05
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115